Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02377050 · ClinicalTrials.gov registry record · NA

Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates

A NA study of Infant, Premature, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT02377050 is a NA study of Infant, Premature that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 224 participants, below the 11,278-participant average among 14 other Infant, Premature trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02377050, a NA study of Infant, Premature, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The primary hypothesis is that preterm infants who are less than or equal to 32 weeks gestation and weigh 1001-2500 grams at birth will have an increase in weight gain with a feeding goal of 180-200 ml/kg/day more than the commonly used feeding goal of 140-160 ml/kg/day

Conditions Studied

Interventions

  • OTHER Higher Volume Feeding Goal

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2015-01
Est. Completion 2018-06
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02377050

The ClinicalTrials.gov registry entry for NCT02377050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 11,278-participant average among 14 other Infant, Premature trials with a reported enrollment target (98% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infant, Premature appearing as the primary indexed condition, and to 1 intervention - of which Higher Volume Feeding Goal is the first listed.

NCT02377050 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT02377050 about?

NCT02377050 is a clinical study titled "Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates". The primary hypothesis is that preterm infants who are less than or equal to 32 weeks gestation and weigh 1001-2500 grams at birth will have an increase in weight gain with a feeding goal of 180-200 ml/kg/day more than the commonly used feeding goal of 140-160 ml/kg/day

What is the current status of trial NCT02377050?

This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2015-01. Estimated completion is 2018-06.

What conditions does trial NCT02377050 study?

This clinical trial studies the following conditions: Infant, Premature.

What interventions are being tested in trial NCT02377050?

The interventions under investigation include: Higher Volume Feeding Goal (OTHER).

Who is sponsoring clinical trial NCT02377050?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02377050 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant, Premature

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.